New drug combo under watch for Kids' cancer side effects
NCT ID NCT05481437
First seen Apr 18, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This study tracks side effects of the drug ADCETRIS (brentuximab vedotin) when used with standard chemotherapy in children and teenagers with untreated Hodgkin lymphoma. Researchers will monitor for serious side effects like bone marrow suppression, nerve damage, and lung problems over 26 weeks. The study is only for patients under 18 who have not had treatment before.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Takeda selected site
RECRUITINGTokyo, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.